| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $-0.01 (Miss by $-0.15) |
| EPS GAAP Actual | $-0.01 (Miss by $-0.15) |
| Revenue Actual | $0.112931B |
| Revenue Surprise | Beat by $112.931M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.49989 | 5.24 | 0.427 | 0.58365 | 1 |
| Dec 2028 | 0.11425 | 22.93 | 0.10866 | 0.12024 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.15 | -0.15 | 0.112931B | 37.01% | 112.93M |
| FQ2 2025 (Jun 2025) | 0.0762 | 0.0762 | 0.097304B | 34.28% | 97.3M |
| FQ1 2025 (Mar 2025) | -0.1 | -0.1 | 0.07659B | 58.8% | 76.59M |
| FQ4 2024 (Dec 2024) | 0.0038 | 0.0038 | 0.064551B | 100% | 64.55M |
| FQ3 2024 (Sep 2024) | 0.0043 | 0.0043 | 0.07113B | 100% | 71.13M |
| FQ2 2024 (Jun 2024) | 0.0346 | 0.0346 | 0.0639498B | 100% | 63.95M |
| FQ1 2024 (Mar 2024) | -0.0203 | -0.0203 | 0.0315534B | 100% | 31.55M |
| FQ4 2023 (Dec 2023) | -0.0263 | -0.0263 | 0B | NAN% | 0M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.19732 | -- | 0.19732 | 0.19732 | 1 |
| FQ3 2027 (Sep 2027) | 0.20719 | -- | 0.20719 | 0.20719 | 1 |
| FQ2 2027 (Jun 2027) | 0.21089 | -- | 0.21089 | 0.21089 | 1 |
| FQ1 2027 (Mar 2027) | 0.21958 | -- | 0.21958 | 0.21958 | 1 |
| FQ4 2026 (Oct 2026) | 0.0514 | -- | 0.0514 | 0.0514 | 0 |
| FQ3 2026 (Jul 2026) | 0.0538 | 378.81 | 0.0538 | 0.0538 | 0 |
| FQ2 2026 (Jun 2026) | 0.10603 | 28.13 | 0.10603 | 0.10603 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.18B | -- | 0.18B | 0.18B | 1 |
| FQ3 2027 (Sep 2027) | 0.19B | -- | 0.19B | 0.19B | 1 |
| FQ2 2027 (Jun 2027) | 0.19B | -- | 0.19B | 0.19B | 1 |
| FQ1 2027 (Mar 2027) | 0.2B | -- | 0.2B | 0.2B | 1 |
| FQ4 2026 (Oct 2026) | 0.12B | -- | 0.12B | 0.12B | 0 |
| FQ3 2026 (Jul 2026) | 0.12B | 4.63 | 0.12B | 0.12B | 0 |
| FQ2 2026 (Jun 2026) | 0.17B | 41.16 | 0.17B | 0.17B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.15 | -0.15 | 100% | |
| FQ2 2025 (Jun 2025) | 0.0762 | 0.0762 | 100% | |
| FQ1 2025 (Mar 2025) | -0.1 | -0.1 | 100% | |
| FQ4 2024 (Dec 2024) | 0.0038 | 0.0038 | 100% | |
| FQ3 2024 (Sep 2024) | 0.0043 | 0.0043 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0346 | 0.0346 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0203 | -0.0203 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0263 | -0.0263 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.11B | $112.93M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.1B | $97.3M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.08B | $76.59M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.06B | $64.55M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.07B | $71.13M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.06B | $63.95M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.03B | $31.55M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |